# Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi Panel

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adoption-of-biosimilar-infliximab-for-rheumatoid-arthritis-ankylosing/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tim A. Kanters,Jelena Stevanović,Isabelle Huys,Arnold G. Vulto,Steven Simoens |
| Citations | 30 |
| DOI | 10.3389/fphar.2017.00322 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fphar.2017.00322/pdf |
| OpenAlex ID | https://openalex.org/W2617581275 |
| PMID | 28620302 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Tim A. Kanters](https://scholariq.org/researchers/tim-a-kanters/)

## Paper journal

- [Frontiers in Pharmacology](https://scholariq.org/journals/frontiers-in-pharmacology/)

## Paper primary topic

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

## Paper topics

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.